A coalition of experts has urged the U.S. Food and Drug Administration to establish clear safety and access standards for psychedelic medicines, Reuters reported.
The call coincides with an FDA hearing that is concentrating on how to safeguard patients while expanding availability, and includes testimony from Jacksonville veterans describing their experiences with psychedelic‑assisted PTSD treatment.
ALSO READ | Juror Claims Feminist Agenda Drove Lindsay Clancy Verdict in Massachusetts Trial
During the same hearing, FDA officials outlined a plan to accelerate the rollout of approved psychedelic therapies, underscoring the cultural weight of a potential first approval.
